社会平均工资水平与“药占比”的相关性研究
|
摘要
目的探讨社会平均工资对"药占比"的影响,为我国监测和管理"药占比",合理控制药品费用提供支持。方法基于经济合作与发展组织数据库,采用2006~2015年24个经济合作与发展组织(OECD)欧洲国家的年度"药占比"数据以及社会年平均工资数据,描述性分析"药占比"随时间和年平均工资的变化趋势;采用15个欧元区国家2006～2015年数据构建面板数据计量模型,分析年平均工资和时间与"药占比"的相关性。结果研究结果显示,"药占比"的倒数与年平均工资和时间存在正相关关系,且具有统计学上的显著性。即"药占比"随着社会平均工资的增加或时间的推移而下降。结论制定"药占比"控制指标时,要充分考虑本地社会平均工资水平的影响。
OBJECTIVE To explore the effect of social average wages on the pharmaceutical expenditure as a share of total health expenditure( PE/THE),provide support for the reduction of PE/THE scientifically,and reasonably controlling pharmaceutical expenditure. METHODS Data from the Organization for Economic Co-operation and Development database were used in this analysis,which concluded the indicator PE/THE and the annual average wage data of 24 OECD countries. Time trends of PE/THE and the relationship between PE/THE and average annual wages were examined. The data of 15 Eurozone countries from 2006 to 2015 were used to build panel data model to analyze the correlation between annual average wage and time and PE/THE.RESULTS The results of the study show that the reciprocal of the PE/THE was positively correlated with the average annual wages and time,and was statistically significant. That is,with the increase of the annual average wages or time goes by,the PE/THE declines. CONCLUSION When formulating the policy of PE/THE,the influencing factor of average annual wages should be taken into full consideration.
OBJECTIVE To explore the effect of social average wages on the pharmaceutical expenditure as a share of total health expenditure( PE/THE),provide support for the reduction of PE/THE scientifically,and reasonably controlling pharmaceutical expenditure. METHODS Data from the Organization for Economic Co-operation and Development database were used in this analysis,which concluded the indicator PE/THE and the annual average wage data of 24 OECD countries. Time trends of PE/THE and the relationship between PE/THE and average annual wages were examined. The data of 15 Eurozone countries from 2006 to 2015 were used to build panel data model to analyze the correlation between annual average wage and time and PE/THE.RESULTS The results of the study show that the reciprocal of the PE/THE was positively correlated with the average annual wages and time,and was statistically significant. That is,with the increase of the annual average wages or time goes by,the PE/THE declines. CONCLUSION When formulating the policy of PE/THE,the influencing factor of average annual wages should be taken into full consideration.
引文
[1]SUN J,HU C J,STUNTZ M,et al.A review of promoting access to medicines in China-problems and recommendations[J].BMC Health Serv Res,2018,18(1):125.
[2]MOSSIALOS E,GE Y,HU J,et al.Pharmaceutical Policy in China:Challenges and Ppportunities for Reform[M].the Vnited Kingdoin:World Health Organization,2016:56.
[3]CHEN G.Can drug proportion management control medical expenditure?Based on theoretical and empirical research of county hospitals[J].Collect Essays Finance Econ(财经论丛),2014,8(8):87.
[4]XU G,WANG C.Regulation value and social effect analysis of drug proportion in the hospital management and evaluation[J].J China Pharm(中国药房),2015(34):4762-4765.
[5]OECD.health at a glance 2017:OECD Indicators[EB/OL].(2017-11-10)[2018-01-20].http://dx.doi.org/10.1787/health_glance-2017-en.
[6]LI Y M.The Verification of the Balassa-Samuelson effect in China(1990-2012)[D].Beijing:Capital University of Economics and Business,2014.
[7]SHI L,YANG H Y,CHENG G,et al.Time trends and determinants of pharmaceutical expenditure in China(1990-2009)[J].Pharmacoeco,2014,32(3):257-264.
[8]OECD.OECD Data:Pharmaceutical spending(indicator)[EB/OL].[2017-12-01]https://data.oecd.org/healthres/pharmaceutical-spending.htm.
[9]OECD Statistic.Average annual wages[EB/OL].[2018-02-20].http://stats.oecd.org/Index.aspx?Data Set Code=AV_AN_WAGE.
[10]OECD.Health at a glance:Europe 2016[EB/OL].(2016-12-23)[2017-12-20].http://dx.doi.org/10.1787/9789264265592-en.
[11]ZHAO H Z.Medical labor value and medical service charges[J].Chin Health Econ(中国卫生经济),1996(2):19-20.
[12]WANG G X.Economic analysis of medical needs[J].Commercial Res(商业研究),2007,(5):168-170.
[2]MOSSIALOS E,GE Y,HU J,et al.Pharmaceutical Policy in China:Challenges and Ppportunities for Reform[M].the Vnited Kingdoin:World Health Organization,2016:56.
[3]CHEN G.Can drug proportion management control medical expenditure?Based on theoretical and empirical research of county hospitals[J].Collect Essays Finance Econ(财经论丛),2014,8(8):87.
[4]XU G,WANG C.Regulation value and social effect analysis of drug proportion in the hospital management and evaluation[J].J China Pharm(中国药房),2015(34):4762-4765.
[5]OECD.health at a glance 2017:OECD Indicators[EB/OL].(2017-11-10)[2018-01-20].http://dx.doi.org/10.1787/health_glance-2017-en.
[6]LI Y M.The Verification of the Balassa-Samuelson effect in China(1990-2012)[D].Beijing:Capital University of Economics and Business,2014.
[7]SHI L,YANG H Y,CHENG G,et al.Time trends and determinants of pharmaceutical expenditure in China(1990-2009)[J].Pharmacoeco,2014,32(3):257-264.
[8]OECD.OECD Data:Pharmaceutical spending(indicator)[EB/OL].[2017-12-01]https://data.oecd.org/healthres/pharmaceutical-spending.htm.
[9]OECD Statistic.Average annual wages[EB/OL].[2018-02-20].http://stats.oecd.org/Index.aspx?Data Set Code=AV_AN_WAGE.
[10]OECD.Health at a glance:Europe 2016[EB/OL].(2016-12-23)[2017-12-20].http://dx.doi.org/10.1787/9789264265592-en.
[11]ZHAO H Z.Medical labor value and medical service charges[J].Chin Health Econ(中国卫生经济),1996(2):19-20.
[12]WANG G X.Economic analysis of medical needs[J].Commercial Res(商业研究),2007,(5):168-170.